Established in 1985, the APG represents eleven of the largest US research-based bio-pharmaceutical companies with a presence in the UK. The Group works with the Government, the NHS and other stakeholders to help ensure the UK remains a leading environment for life sciences innovation and investment. Our focus is on supporting patient access to innovative medicines and contributing to a strong and sustainable healthcare system. Together we seek to support a receptive environment for inward investment and appropriate access for a stronger NHS, economic growth and a thriving life sciences sector.